BetterLife to Present at the Emerging Growth Conference
July 19, 2021 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, July 19, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA:NPAU ), an emerging biotechnology company...
BetterLife Provides H1 2021 Progress Update
July 12, 2021 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, July 12, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotechnology company...
BetterLife Secures Mitacs Funding in Collaboration with Carleton University Research Team for TD-0148A Preclinical Depression Studies
June 24, 2021 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, June 24, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
BetterLife Added to Horizons Psychedelic Stock Index ETF
March 29, 2021 08:00 ET
|
BetterLife Pharma
VANCOUVER, March 29, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB : BETRF / FRA: NPAU) is pleased to announce that it has been added to the...
BetterLife Enters Research Agreement with Carleton University for TD-0148A Depression Studies
March 08, 2021 08:00 ET
|
BetterLife Pharma
VANCOUVER, March 08, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development...
BetterLife Engages Eurofins CDMO for Next Generation Psychedelic TD-0148A Manufacturing
March 03, 2021 08:00 ET
|
BetterLife Pharma
VANCOUVER, March 03, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development...
BetterLife Engages Eurofins Discovery for its Next Generation Psychedelics 2-bromo-LSD FDA IND-enabling Pharmacology Studies
January 28, 2021 02:00 ET
|
BetterLife Pharma
VANCOUVER, Jan. 27, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development and...
BetterLife Confirms Non-controlled Status of 2-bromo-LSD with Health Canada
January 19, 2021 02:00 ET
|
BetterLife Pharma
VANCOUVER, Jan. 18, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development and...
BetterLife Provides Shareholder Update and 2021 Product Development Roadmap
January 12, 2021 02:00 ET
|
BetterLife Pharma
VANCOUVER, Jan. 11, 2021 (GLOBE NEWSWIRE) -- VANCOUVER, January 12, 2021 - BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech focused...
BetterLife Announces Formation of Next Generation Psychedelic Research Advisory Board
January 07, 2021 09:00 ET
|
BetterLife Pharma
VANCOUVER, Jan. 07, 2021 (GLOBE NEWSWIRE) -- January 7, 2021 - BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company, is pleased...